Glutathione

Glutathione (GSH) is the body's master antioxidant — a small tripeptide built from three amino acids (glutamate, cysteine, and glycine) that nearly every cell makes for itself. It is the workhorse behind a huge amount of everyday cellular housekeeping: it directly neutralises free radicals and peroxides, it regenerates the 'spent' forms of vitamins C and E back into their active antioxidant states, and it is central to the liver's phase-II detoxification, where it conjugates toxins and drug metabolites so they can be safely excreted. The rate-limiting ingredient for making it is cysteine — which is exactly why the precursor NAC (N-acetylcysteine) is so often discussed alongside glutathione: NAC delivers cysteine and lets the body build its own GSH.

Here is the honest core every buyer needs, stated up front: the oral bioavailability of plain reduced glutathione is genuinely debated. Glutathione is a peptide, and the digestive tract is built to break peptides apart before they reach the bloodstream. In Witschi 1992, a single 3 g oral dose failed to raise plasma glutathione at all, and the authors called systemic availability 'negligible in man.' In Allen 2011, 500 mg a day for four weeks moved no oxidative-stress biomarkers. And yet Richie 2015 found that 250 mg and 1000 mg a day, taken for six full months, did raise the body's glutathione stores — slowly and cumulatively. The reconciling picture is that plain oral GSH can probably replete you over months at a real dose, but it is not the instant antioxidant infusion the marketing implies.

That debate is why supplemental glutathione comes in several forms, and why form matters more than brand. Liposomal glutathione wraps the molecule in a phospholipid shell to shepherd it past digestion; Sinha 2018 showed liposomal GSH raised body stores and immune markers. S-acetyl glutathione carries an acetyl group engineered to survive the gut and be cleaved off inside the cell. And clinically-referenced branded reduced glutathione — Setria, from Kyowa in Japan (its oral-grade sibling is OPITAC) — is the named raw material behind most of the better human work. These delivery strategies are the industry's direct answer to a real scientific objection, not marketing flourishes.

Inside the cell, glutathione works as a redox buffer. It cycles between a reduced form (GSH) and an oxidised form (GSSG): the reduced form donates electrons to neutralise reactive oxygen species, becomes oxidised in the process, and is then recycled back to the active reduced form by the enzyme glutathione reductase, which is why cofactors that support that recycling — such as alpha lipoic acid — are often stacked with it. This GSH:GSSG ratio is one of the body's core markers of oxidative balance. Glutathione also acts as the substrate for glutathione peroxidase (a selenium-dependent enzyme) to detoxify peroxides, and for glutathione-S-transferases in the liver to conjugate and clear toxins and drug metabolites — the phase-II detox role.

The whole reason the form question dominates is that none of this can happen if the molecule doesn't get into your cells. Oral plain GSH must first survive the gut, and the evidence that it does so meaningfully is mixed (Witschi 1992 and Allen 2011 negative on plasma and biomarkers; Richie 2015 positive on body stores over six months). Liposomal encapsulation aims to physically protect the tripeptide through digestion and improve uptake — the mechanism behind the body-store and immune-marker gains in Sinha 2018. S-acetyl glutathione aims to chemically protect it with an acetyl group cleaved intracellularly, though its human outcome evidence is thinner and largely mechanistic. And the precursor route — supplying cysteine via NAC so the body synthesises its own glutathione — sidesteps the absorption problem entirely, which is why it is the cheaper alternative many clinicians reach for first.

A note on the most-marketed claim: glutathione is widely sold, especially in some regions and via intravenous clinics, as a skin-lightening agent (it can shift melanin synthesis toward lighter pigment). SAC does not endorse or score that use. The oral evidence for skin lightening is limited and short-term, intravenous glutathione for cosmetic whitening has drawn safety warnings from regulators, and it is simply not the use case we rank these products on — we evaluate glutathione as an antioxidant, liver-support, and immune supplement.